Despite widespread decreases in most amino acids, circulating levels of kynurenine, a tryptophan catabolite (and other kynurenine pathway intermediates) were confirmed [1,4,33,34,35] to be significantly increased in COVID-19 patients as a function of IL-6 levels (Figure 2A,B). The gene discussed is IL6; the disease is COVID-19.